Therapeutic Apheresis

(P-TA-1) Less Is Sometimes More: Low Volume Depletion for Isovolemic Hemodilution Red Blood Cell Exchange as an Effective and Safe Strategy in Sickle Cell Disease

(P-TA-2) Automated Red Cell Exchange – A Life Saving Measure In Methemoglobinemia, Our Centre Study

(P-TA-3) Characterization Of Spirometric Response To Therapeutic Plasma Exchange (TPE) And Factors Associated With Respiratory Distress In Myasthenia Gravis Patients

(P-TA-4) Chronic Automated Red Cell Exchange Therapy for Sickle Cell Disease: A Tertiary Center Decade-Long Experience

(P-TA-5) Drug-Induced Thrombocytopenia after SARS CoV-2 Monoclonal Antibody Administration Treated with Plasma Exchange

(P-TA-6) Factors Affecting Triglyceride Clearance in Patients with Hypertriglyceridemia Receiving Plasmapheresis on Continuous and Intermittent Flow Apheresis Devices

(P-TA-7) Overcoming the Prozone-Like Effect on Luminex Single Antigen Testing in the Setting of Therapeutic Plasma Exchange: A Case Report

(P-TA-8) Preventative Plasmapheresis in a Diabetic Pregnant Patient with Hypertriglyceridemia and Distal Pancreatectomy

(P-TA-9) Red cell exchange and plasma exchange in the treatment of fat embolism syndrome

(P-TA-10) Role Of Therapeutic Plasma Exchange In Immune Checkpoint Inhibitor Therapy-Induced Adverse Events

(P-TA-11) Successful Management of Anti-PP1Pk Alloimmunization In Pregnancy With Therapeutic Plasma Exchange and Intravenous Immunoglobulin

(P-TA-12) Therapeutic Plasma Exchange for Management of Heparin-Induced Thrombocytopenia and Thrombosis: Results of a Single Center Based Study

(P-TA-13) Therapeutic Plasma Exchange Reduces SARS-CoV-2 Vaccine-Induced Antibody Levels